Sermorelin/GHRP-6 — Class I drug recall D-1052-2014
Terminated recall by NuVision Pharmacy, Inc., reported 2014-02-05, distributed nationwide. Lack of Assurance of Sterility: The recall is being initiated due to a lack of sterility assurance and concern
| Recall number | D-1052-2014 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | NuVision Pharmacy, Inc., Dallas, TX, United States |
| Recall initiated | 2013-04-15 |
| Classified | 2014-01-30 |
| Reported by FDA | 2014-02-05 |
| Terminated | 2017-02-08 |
| Distributed | Nationwide (US) |
| Quantity | 122 vials |
| Reason classes | sterility |
| Expiration dates | 2013-10-17 |
Product
Sermorelin/GHRP-6, 3 mg/3 mg, 5 mL vial, Stock # 21740, Compounded by NuVision Pharmacy, Dallas, TX 75244
Reason for recall
Lack of Assurance of Sterility: The recall is being initiated due to a lack of sterility assurance and concerns associated with the quality control processes identified during an FDA inspection.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1052-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.